|
09 Jul 2020 |
Precision BioSciences Regains Rights to In Vivo Hepatitis B Virus Program
|
|
08 Jul 2020 |
Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties
|
|
07 Jul 2020 |
Celixir provides update on ongoing clinical programme with lead therapeutic candidate CLXR-001
|
|
07 Jul 2020 |
Johns Hopkins Reports Promising Clinical Data in COVID-19 ARDS Treated with Cellenkos' Cord Blood T-Regulatory Cells
|
|
07 Jul 2020 |
Cellectis Reports Clinical Hold Placed on MELANI-01 Study
|
|
06 Jul 2020 |
GenSight Biologics Reports Sustained Efficacy and Safety Among LHON Patients Three Years After LUMEVOQ® Treatment
|
|
03 Jul 2020 |
AffyImmune Therapeutics presents novel CAR T development programs at the annual meeting of the American Association of Cancer Research
|
|
02 Jul 2020 |
AltruBio moves forward with clinical development of Neihulizumab in Steroid-Refractory Acute Graft-versus-Host Disease after encouraging Phase 1a results
|
|
02 Jul 2020 |
Xenetic Biosciences, Inc. Provides Development Update for Its Personalized CAR T Platform Technology, XCART(TM)
|
|
01 Jul 2020 |
BioCardia Announces Activation of Pivotal Trial Studying CardiAMP Cell Therapy Trial to Treat Chronic Myocardial Ischemia
|
|
01 Jul 2020 |
Amniox Announces Initiation for First of Two Phase 3 Clinical Trials of Cryopreserved Umbilical Cord TTAX01 Allograft to Treat Complex Wagner Grade 3-4 Diabetic Foot Ulcers
|
|
30 Jun 2020 |
AOBiome Reports Successful Clinical Trials (Phase 2a in Adults and Phase 1b in Pediatrics) in Pruritus (Itch) Associated with Atopic Dermatitis
|
|
29 Jun 2020 |
SFA Therapeutics Announces FDA Approval To Begin IND Trial
|
|
29 Jun 2020 |
PTC Therapeutics Announces CHMP Recommendation of Translarna™ (ataluren) Label Update for Non-Ambulatory Patients with Duchenne Muscular Dystrophy
|
|
29 Jun 2020 |
Rocket Pharmaceuticals Announces FDA Clearance of IND for RP-L401 Gene Therapy for Infantile Malignant Osteopetrosis
|
|
28 Jun 2020 |
Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Casimersen (SRP-4045) for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45
|
|
28 Jun 2020 |
Verve Therapeutics Presents New Data in Non-Human Primates Validating Gene Editing as a Treatment Approach for Coronary Heart Disease at the ISSCR 2020 Virtual Annual Meeting
|
|
26 Jun 2020 |
Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer
|
|
26 Jun 2020 |
Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-007 in Parkinson's Disease
|
|
26 Jun 2020 |
Highlight Therapeutics announces first patient dosed in Phase IIa study in liver metastasis
|
|
26 Jun 2020 |
Nurix Therapeutics Announces Formation of DeCART Therapeutics to Advance New CAR T Therapies Using Targeted Protein Modulation
|
|
25 Jun 2020 |
Acceleron Presents Topline Results of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial Hypertension
|
|
25 Jun 2020 |
uniQure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy
|
|
24 Jun 2020 |
Medigene enters Phase I clinical development with its TCR-T immunotherapy MDG1021 in hematological cancers
|
|
23 Jun 2020 |
Medigene’s PD1-41BB Switch Receptor Enhances TCR-T Cell Activity Towards Solid Tumors
|
